FDA Inspection
Apitoria Research Centre (A Division of Apitoria Pharma Private Limited)FDA Inspection 1239742 - Apitoria Research Centre (A Division of Apitoria Pharma Private Limited) - May 24, 2024
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Apitoria Research Centre (A Division of Apitoria Pharma Private Limited), with an inspection on May 24, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 24, 2024
- Product Type
- Drugs
View Company Profile
ID · d6db5221-3575-4a41-8bdd-06da92c6bec0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1239742
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.68(b)input/output verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Apitoria Research Centre (A Division of Apitoria Pharma Private Limited)
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |